Finance
Finance
HomeKRK • WSE
Krka dd Novo Mesto
zł 850.00
Aug 1, 5:55:53 PM GMT+2 · PLN · WSE · Disclaimer
StockPL listed security
Previous close
zł 856.00
Day range
zł 838.00 - zł 868.00
Year range
zł 560.00 - zł 900.00
Market cap
6.76B EUR
Avg Volume
253.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2025Y/Y change
Revenue
526.43M5.44%
Operating expense
168.68M3.20%
Net income
93.66M-23.87%
Net profit margin
17.79-27.80%
Earnings per share
EBITDA
Effective tax rate
21.44%
Total assets
Total liabilities
(EUR)Jun 2025Y/Y change
Cash and short-term investments
762.65M
Total assets
3.15B
Total liabilities
638.02M
Total equity
2.51B
Shares outstanding
30.54M
Price to book
10.50
Return on assets
10.76%
Return on capital
13.54%
Net change in cash
(EUR)Jun 2025Y/Y change
Net income
93.66M-23.87%
Cash from operations
81.74M-41.86%
Cash from investing
Cash from financing
-10.72M-150.68%
Net change in cash
61.02M-69.98%
Free cash flow
About
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2023, Krka Group's total sales amounted to 1.806 billion euros. The net profit of the Krka Group totalled €313.7 million. Krka sells products to more than 70 countries. In Slovenia the company has production sites in Ločna and Bršljin, Krško, Šentjernej and Ljutomer; several departments are spread across various parts of Ljubljana as well. Krka also has production and distribution centers in Russia, Poland, Croatia, and Germany. At the end of 2023, Krka Group had 12,753 employees. Wikipedia
Founded
Apr 23, 1954
Website
Employees
13,006
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu